MicroRNAs (miRNAs) released from the activated microglia upon neurotropic virus infection may exacerbate the neuronal damage. Here, we identified let-7a and let-7b (let-7a/b) as one of the essential miRNAs over-expressed upon Japanese Encephalitis virus (JEV) infection and released in the culture supernatant of the JEV-infected microglial cells through extracellular vesicles. The let-7a/b was previously reported to modulate inflammation in microglial cells through Toll-like receptor 7 (TLR7) pathways; although their role in accelerating JEV pathogenesis remain unexplored. Therefore, we studied the role of let-7a/b in modulating microglia-mediated inflammation during JEV infection and investigated the effect of let-7a/b-containing exosomes on primary neurons. To this end, we examined let-7a/b and NOTCH signaling pathway in TLR7 knockdown (KD) mice. We observed that TLR7 KD or inhibition of let-7a/b suppressed the JEV-induced NOTCH activation possibly via NF-κB dependent manner and subsequently, attenuated JEV-induced TNFα production in microglial cells. Furthermore, exosomes secreted from let-7a/b over-expressed microglia when transferred to uninfected mice brain induced caspase activation. Exosomes secreted from virus-infected or let-7a/b over-expressed microglia when co-incubated with mouse neuronal (Neuro2a) cells or primary cortical neurons also facilitated caspase activation leading to neuronal death. Thus, our results provide evidence for the multifaceted role of let-7a/b miRNAs in JEV pathogenesis. Let-7a/b can interact with TLR7 and NOTCH signaling pathway and enhance TNFα release from microglia. On the other hand, the exosomes secreted by JEV-infected microglia can activate caspases in uninfected neuronal cells which possibly contribute to bystander neuronal death. Cover Image for this issue: doi: 10.1111/jnc.14506.
Pubmed ID: 30556910 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets GAPDH
View all literature mentionsThis polyclonal targets RELA
View all literature mentionsThis polyclonal targets TLR7
View all literature mentionsThis monoclonal targets Actin, beta
View all literature mentionsThis monoclonal targets Caspase 9
View all literature mentionsThis polyclonal targets active Caspase 7 antibody
View all literature mentionsThis monoclonal targets NF-KappaB p65, phospho (Ser536)
View all literature mentionsThis monoclonal targets Iba1/AIF1
View all literature mentionsThis polyclonal targets activated Notch1
View all literature mentionsThis monoclonal targets Human CD63
View all literature mentionsThis monoclonal targets Cleaved PARP antibody [E51]
View all literature mentionsThis monoclonal targets Casp3
View all literature mentionsThis monoclonal targets Japanese encephalitis virus E glycoprotein
View all literature mentionsThis monoclonal targets TRANSFERRIN RECEPTOR
View all literature mentionsMus musculus with name BALB/cJ from IMSR.
View all literature mentionsThis monoclonal targets Actin, beta
View all literature mentionsThis monoclonal targets Actin, beta
View all literature mentionsThis polyclonal targets RELA
View all literature mentionsThis polyclonal targets GAPDH
View all literature mentionsThis monoclonal targets Human CD63
View all literature mentionsThis monoclonal targets NF-KappaB p65, phospho (Ser536)
View all literature mentionsThis polyclonal targets activated Notch1
View all literature mentionsThis monoclonal targets Iba1/AIF1
View all literature mentionsThis polyclonal targets TLR7
View all literature mentionsThis polyclonal targets active Caspase 7 antibody
View all literature mentionsThis monoclonal targets Cleaved PARP antibody [E51]
View all literature mentionsThis monoclonal targets Casp3
View all literature mentionsThis monoclonal targets Caspase 9
View all literature mentionsMus musculus with name BALB/cJ from IMSR.
View all literature mentions